Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Cell Point (India) Ltd
Cell Point (India) Ltd

Cell Point (India) Ltd (CELLPOINT) Share Price

  • Sector: Retail (Small Cap)
  • Volume: 2,400
Jul 15, 2025
  • NSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹19.00
₹0.00 (0.00%)
19.00Low
Today’s Performance
19.00High
15.60Low
52 Week’s Performance
37.60High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-%
  • 1 Week1.06%
  • 1 Month1.88%
  • 3 Months2.43%
  • 6 Months-27.48%
  • 1 Year-47.44%
  • 3 Years-41.52%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.49
  • 52-Week Low (₹)15.60
  • 52-Week High (₹)37.60
  • Price-to-Book (X)*0.48
  • Dividend Yield (%)1.32
  • Price-to-Earnings (P/E) (X)*15.70
  • Earnings Per Share (₹)1.21
  • Market Cap (₹ Cr.)*35.50
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"Why Wasn’t I Invited?”: CM Siddaramaiah Writes To PM Modi Over Sigandur Bridge Row3:20"Why Wasn’t I Invited?”: CM Siddaramaiah Writes To PM Modi Over Sigandur Bridge Row
EV Challenges & Auto Slowdown: Where Should Retail Investors Put Their Money?2:43EV Challenges & Auto Slowdown: Where Should Retail Investors Put Their Money?
How ISRO Saved NASA’s Ax-4 Mission: The Inside Story Of Shubhanshu Shukla’s Historic Journey8:01How ISRO Saved NASA’s Ax-4 Mission: The Inside Story Of Shubhanshu Shukla’s Historic Journey
Jaishankar–Xi Meeting: India Flags Border Tensions, Rare Earth Crisis & Trade Blocks3:07Jaishankar–Xi Meeting: India Flags Border Tensions, Rare Earth Crisis & Trade Blocks
Pune Porsche Crash: Juvenile Board Rejects Adult Trial For 17-Year-Old | Victims’ Families Outraged2:53Pune Porsche Crash: Juvenile Board Rejects Adult Trial For 17-Year-Old | Victims’ Families Outraged
Tesla Opens First Experience Center In Mumbai | CM Fadnavis Welcomes Tesla To India2:59Tesla Opens First Experience Center In Mumbai | CM Fadnavis Welcomes Tesla To India
Should You Exit Large IT Stocks? A Look at TCS, HCL & Market Trends2:55Should You Exit Large IT Stocks? A Look At TCS, HCL & Market Trends
Anthem Biosciences IPO Day 2 Update: GMP, Broker Views, Key Risks4:32Anthem Biosciences IPO Day 2 Update: GMP, Broker Views, Key Risks
Flash Floods In Rajasthan Trigger Economic Crisis—Crops, Roads, Markets Submerged1:47Flash Floods In Rajasthan Trigger Economic Crisis—Crops, Roads, Markets Submerged
Planning To SIPs In Small-Cap Funds? Superstar Fund Made 75 Lakhs Of 14.4 Lakhs In 12 YearsPlanning To SIPs In Small-Cap Funds? Superstar Fund Made 75 Lakhs Of 14.4 Lakhs In 12 Years11:54Planning To SIPs In Small-Cap Funds? Superstar Fund Made 75 Lakhs Of 14.4 Lakhs In 12 Years
View more

bt_logoFAQ's

What was Cell Point (India) Ltd share price previously?
Cell Point (India) Ltd share price was down by 0.00% from the previous closing price of ₹19.00.
Who are peers of Cell Point (India) Ltd?
The peers of Cell Point (India) Ltd are Avenue Supermarts Ltd, Trent Ltd, Vishal Mega Mart Ltd, Brainbees Solutions Ltd, Aditya Birla Lifestyle Brands Ltd, Medplus Health Services Ltd, Cartrade Tech Ltd.
Who is/are the promoter/promoters of Cell Point (India) Ltd?
The promotor/promotors of Cell Point (India) Ltd are Mohan Prasad Panday, Bala Balaji Panday, Ananda Rao Ravada, Kiranmai Panday, Kakshayani Sekharamantri, Chandra Sekhar Raghavapudi.
What has been 52-week high of Cell Point (India) Ltd stocks?
The highest price of Cell Point (India) Ltd stock is ₹37.60 in the last 52-week.
What is the share price of Cell Point (India) Ltd (CELLPOINT) today on NSE?
As on Jul 15, 2025 Cell Point (India) Ltd (CELLPOINT)’s share price on NSE is Rs 19
What is the market cap of Cell Point (India) Ltd (CELLPOINT)?
The current market capitalisation of Cell Point (India) Ltd (CELLPOINT) is 35.50 crores
What is Cell Point (India) Ltd Share symbol?
The symbol of Cell Point (India) Ltd is CELLPOINT.
What is the PE ratio of Cell Point (India) Ltd (CELLPOINT)?
The current PE ratio of Cell Point (India) Ltd (CELLPOINT) is 15.70.
What is the PB ratio of Cell Point (India) Ltd (CELLPOINT)?
The current PB ratio of Cell Point (India) Ltd (CELLPOINT) is 0.48.
Today’s High & Low share prices of Cell Point (India) Ltd (CELLPOINT) on NSE?
Today, the share price of Cell Point (India) Ltd (CELLPOINT) on NSE touched a high of Rs 19 and a low of Rs 19
What price did Cell Point (India) Ltd (CELLPOINT) shares open on the NSE today?
On NSE, the share price of Cell Point (India) Ltd (CELLPOINT) opened at Rs 19
What is the 52-week high of Cell Point (India) Ltd (CELLPOINT)?
The 52-week high price of Cell Point (India) Ltd (CELLPOINT) is Rs 37.60
What is the 52-week low of Cell Point (India) Ltd (CELLPOINT)?
The 52-week low price of Cell Point (India) Ltd (CELLPOINT) is Rs 15.60

bt_logoAbout Cell Point

Cell Point (India) Ltd, incorporated in the year 2013, has its registered office in Door No. 30-15-139/F/5,6 Ward, No.27 Ram's Arcade Dabagardens, Visakhapatnam, Andhra Pradesh, 530020, 91-9000113897. The main industry in which Cell Point (India) Ltd operates is Trading.

Auditor/Auditors for Cell Point (India) Ltd is/are Rao & Kumar. In the main management, is chairman and Chandra Sekhar Raghavapudi is the company secretary for Cell Point (India) Ltd.

  • MPP
    Mohan Prasad PandayManaging Director
  • BBP
    Bala Balaji PandayWhole-time Director
  • ARR
    Ananda Rao RavadaIndependent Director
  • KP
    Kiranmai PandayExecutive Director
  • KS
    Kakshayani SekharamantriIndependent Director
  • CSR
    Chandra Sekhar RaghavapudiCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.